Search Results

SGC0946 1mg  | ≥99%

CSNpharm

SGC0946 is a selective inhibitor of DOT1L methyltransferase with IC50 of 0.3 nM and can kill mixed lineage leukaemia cells.

More Information Supplier Page

SGC0946 5mg  | ≥99%

CSNpharm

SGC0946 is a selective inhibitor of DOT1L methyltransferase with IC50 of 0.3 nM and can kill mixed lineage leukaemia cells.

More Information Supplier Page

SGC0946 50mg  | ≥99%

CSNpharm

SGC0946 is a selective inhibitor of DOT1L methyltransferase with IC50 of 0.3 nM and can kill mixed lineage leukaemia cells.

More Information Supplier Page

SGC0946 10mg  | ≥99%

CSNpharm

SGC0946 is a selective inhibitor of DOT1L methyltransferase with IC50 of 0.3 nM and can kill mixed lineage leukaemia cells.

More Information Supplier Page

Azimilide 2HCl 100mg  | ≥99%

CSNpharm

Azimilide 2HCl, a class III antiarrhythmic compound, blocks the Kv7.1 and Kv11.1 patassium channels. It also inhibits Na+/Ca2+ exchanger in vitro.

More Information Supplier Page

Azimilide 2HCl 5mg  | ≥99%

CSNpharm

Azimilide 2HCl, a class III antiarrhythmic compound, blocks the Kv7.1 and Kv11.1 patassium channels. It also inhibits Na+/Ca2+ exchanger in vitro.

More Information Supplier Page